PE20142079A1 -
VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
- Google Patents
VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
Info
Publication number
PE20142079A1
PE20142079A1PE2014001014APE2014001014APE20142079A1PE 20142079 A1PE20142079 A1PE 20142079A1PE 2014001014 APE2014001014 APE 2014001014APE 2014001014 APE2014001014 APE 2014001014APE 20142079 A1PE20142079 A1PE 20142079A1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=52388251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142079(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Andromaco LabfiledCriticalAndromaco Lab
Priority to PE2014001014ApriorityCriticalpatent/PE20142079A1/en
Publication of PE20142079A1publicationCriticalpatent/PE20142079A1/en
SE REFIERE A UN ANILLO VAGINAL DE LIBERACION SOSTENIDA QUE COMPRENDE MELOXICAM Y UN AGENTE MODULADOR DE LA LIBERACION DEL PRINCIPIO ACTIVO, TAL COMO POLIVINILPIRROLIDONA K-30, QUE LIBERA EL PRINCIPIO ACTIVO POR AL MENOS 90 DIAS, UTIL COMO ANTICONCEPTIVO DE USO CONTINUO EN MUJERES. EL ANILLO VAGINAL COMPRENDE PREFERENTEMENTE 5% A 30% EN PESO DE MELOXICAM, EN RELACION AL PESO TOTAL DE LA FORMULACIONIT REFERS TO A VAGINAL RING OF SUSTAINED RELEASE THAT INCLUDES MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, SUCH AS POLYVINYLPYRROLIDONE K-30, WHICH RELEASES THE ACTIVE PRINCIPLE FOR AT LEAST 90 DAYS, USEFUL AS A CONTRACEPTIVE IN CONTINUOUS USE. THE VAGINAL RING PREFERENTIALLY INCLUDES 5% TO 30% BY WEIGHT OF MELOXICAM, IN RELATION TO THE TOTAL WEIGHT OF THE FORMULATION
PE2014001014A2011-12-292011-12-29
VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
PE20142079A1
(en)
Pharmaceutical dosage form with breaking strength of at least 500 n, containing an active ingredient, 5 to 70% by weight of an inorganic salt, at least 30% by weight of a polyalkylene oxide, wherein the active ingredient is integrated in a controlled release matrix comprising inorganic salt and polyalkylene oxide.
VAGINAL RING INCLUDING DHEA OR DHEA SULFATE AND OPTIONALLY A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL TO INCREASE OVARIAN RESERVE IN WOMEN AND TO RELIEF SYMPTOMS ASSOCIATED WITH MENOPAUSE
VAGINAL RING THAT INCLUDES MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN